Investors Buy Express Scripts Holding Company (ESRX) on Weakness
Investors bought shares of Express Scripts Holding Company (NASDAQ:ESRX) on weakness during trading on Monday. $39.23 million flowed into the stock on the tick-up and $15.66 million flowed out of the stock on the tick-down, for a money net flow of $23.57 million into the stock. Of all equities tracked, Express Scripts Holding had the 27th highest net in-flow for the day. Express Scripts Holding traded down ($0.23) for the day and closed at $60.33
A number of brokerages have recently issued reports on ESRX. UBS AG set a $71.00 target price on shares of Express Scripts Holding and gave the company a “hold” rating in a research report on Tuesday, April 25th. BidaskClub cut shares of Express Scripts Holding from a “sell” rating to a “strong sell” rating in a research report on Friday, August 4th. Morgan Stanley boosted their target price on shares of Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a research report on Thursday, August 10th. Cowen and Company reissued an “outperform” rating and issued a $83.00 target price on shares of Express Scripts Holding in a research report on Friday, June 9th. Finally, Evercore ISI reduced their target price on shares of Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a research report on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Express Scripts Holding currently has an average rating of “Hold” and a consensus price target of $71.17.
The firm has a market capitalization of $34.84 billion, a PE ratio of 10.47 and a beta of 0.90. The company has a 50-day moving average of $62.23 and a 200 day moving average of $64.20.
Express Scripts Holding (NASDAQ:ESRX) last announced its quarterly earnings results on Tuesday, July 25th. The company reported $1.73 EPS for the quarter, topping the Zacks’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion for the quarter, compared to analysts’ expectations of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. The business’s quarterly revenue was up .5% on a year-over-year basis. During the same period in the previous year, the firm earned $1.57 EPS. On average, analysts forecast that Express Scripts Holding Company will post $6.99 EPS for the current year.
Institutional investors have recently made changes to their positions in the company. Burt Wealth Advisors boosted its position in shares of Express Scripts Holding by 11.4% in the second quarter. Burt Wealth Advisors now owns 1,696 shares of the company’s stock worth $108,000 after buying an additional 174 shares during the period. CKW Financial Group boosted its position in shares of Express Scripts Holding by 20.0% in the second quarter. CKW Financial Group now owns 1,800 shares of the company’s stock worth $115,000 after buying an additional 300 shares during the period. Dubuque Bank & Trust Co. boosted its position in shares of Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares during the period. TrimTabs Asset Management LLC bought a new position in shares of Express Scripts Holding during the first quarter worth approximately $121,000. Finally, Capital Analysts LLC boosted its position in shares of Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares during the period. 90.24% of the stock is currently owned by institutional investors and hedge funds.
WARNING: “Investors Buy Express Scripts Holding Company (ESRX) on Weakness” was published by Daily Political and is owned by of Daily Political. If you are viewing this piece of content on another site, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.dailypolitical.com/2017/08/21/investors-buy-express-scripts-holding-company-esrx-on-weakness.html.
About Express Scripts Holding
Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).